News | NCCN Annual Conference signals a new era of coordinated, precision cancer care
The National Comprehensive Cancer Network held its 2026 Annual Conference in Orlando, Florida, attracting more than 1,000 oncology professionals in person and hundreds online. Sessions covered the latest advances in cancer prevention and treatment, clinical guideline updates, optimization of cancer center operations, and care delivery models, highlighting the latest global trends and challenges in cancer care.
Crystal S. Denlinger said that communication and collaboration across institutions are bringing new momentum to oncology: “By sharing best practices and building partnerships, health systems can provide patients with better treatment experiences and outcomes.”
The first plenary session focused on a growing trend: rising cancer incidence among people under 50. Experts said the change may be related to multiple factors, including diet and lifestyle, the gut microbiome, and environmental exposures. Younger patients also face more complex practical challenges during treatment, including career development, parenting responsibilities, and fertility planning.
Experts noted that younger patients are often below routine screening ages, symptoms may be less readily recognized, and cancer is more likely to be advanced at diagnosis. Genetic factors also account for a relatively larger share of cancers in this group, adding complexity to diagnosis and treatment. Christopher Lieu emphasized the need for multidisciplinary, lifelong support, including fertility preservation, psychological care, and long-term follow-up, to improve quality of life and long-term outcomes.
The second plenary shifted to regional disparities in the global cancer burden. Cancer incidence continues to rise worldwide, and most deaths occur in low- and middle-income countries, yet only about 5% of global cancer funding goes to these regions, reflecting a major resource mismatch.
Experts said standardized treatment pathways, expanded vaccination such as HPV vaccination, and wider screening could deliver cost-effective interventions in resource-limited settings. Major barriers include funding cuts, fragmented programs, and shortages of healthcare workers.
Anu K. Agrawal said, “Well-designed programs can have an enormous impact in these regions. The key is integrating resources and coordinating action.” The conference also presented international collaborations, including NCCN's work with the African Cancer Coalition on guidelines for sub-Saharan Africa and guideline localization projects for the Middle East and North Africa.
At the health-system level, the conference introduced its first dedicated oncology program operations track, focusing on improving efficiency through guideline implementation, academic-community collaboration, artificial intelligence (AI), and policy optimization. Lawrence N. Shulman said that longer survival and rising case numbers are placing unprecedented pressure on oncology systems, creating an urgent need to improve capacity through better electronic health records (EHRs), streamlined processes, and technology.
Downloads of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) exceeded 18 million over the past year, reflecting strong global demand for standardized, high-quality cancer care pathways.
More than 300 original research abstracts were also presented, covering clinical oncology, bioinformatics, epidemiology, precision medicine, and quality improvement. Key topics included expanding lung cancer screening, neuroendocrine tumor vaccine research, and improving screening adherence.
Overall, the conference sent a clear signal that future cancer prevention and care will increasingly depend on cross-regional collaboration, standardized pathways, and technology, while balancing the needs of younger patients with global resource allocation.
News | NCCN Annual Conference signals a new era of coordinated, precision cancer care
News | NCCN Annual Conference signals a new era of coordinated, precision cancer care
The National Comprehensive Cancer Network held its 2026 Annual Conference in Orlando, Florida, attracting more than 1,000 oncology professionals in person and hundreds online. Sessions covered the latest advances in cancer prevention and treatment, clinical guideline updates, optimization of cancer center operations, and care delivery models, highlighting the latest global trends and challenges in cancer care.
Crystal S. Denlinger said that communication and collaboration across institutions are bringing new momentum to oncology: “By sharing best practices and building partnerships, health systems can provide patients with better treatment experiences and outcomes.”
The first plenary session focused on a growing trend: rising cancer incidence among people under 50. Experts said the change may be related to multiple factors, including diet and lifestyle, the gut microbiome, and environmental exposures. Younger patients also face more complex practical challenges during treatment, including career development, parenting responsibilities, and fertility planning.
Experts noted that younger patients are often below routine screening ages, symptoms may be less readily recognized, and cancer is more likely to be advanced at diagnosis. Genetic factors also account for a relatively larger share of cancers in this group, adding complexity to diagnosis and treatment. Christopher Lieu emphasized the need for multidisciplinary, lifelong support, including fertility preservation, psychological care, and long-term follow-up, to improve quality of life and long-term outcomes.
The second plenary shifted to regional disparities in the global cancer burden. Cancer incidence continues to rise worldwide, and most deaths occur in low- and middle-income countries, yet only about 5% of global cancer funding goes to these regions, reflecting a major resource mismatch.
Experts said standardized treatment pathways, expanded vaccination such as HPV vaccination, and wider screening could deliver cost-effective interventions in resource-limited settings. Major barriers include funding cuts, fragmented programs, and shortages of healthcare workers.
Anu K. Agrawal said, “Well-designed programs can have an enormous impact in these regions. The key is integrating resources and coordinating action.” The conference also presented international collaborations, including NCCN's work with the African Cancer Coalition on guidelines for sub-Saharan Africa and guideline localization projects for the Middle East and North Africa.
At the health-system level, the conference introduced its first dedicated oncology program operations track, focusing on improving efficiency through guideline implementation, academic-community collaboration, artificial intelligence (AI), and policy optimization. Lawrence N. Shulman said that longer survival and rising case numbers are placing unprecedented pressure on oncology systems, creating an urgent need to improve capacity through better electronic health records (EHRs), streamlined processes, and technology.
Downloads of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) exceeded 18 million over the past year, reflecting strong global demand for standardized, high-quality cancer care pathways.
More than 300 original research abstracts were also presented, covering clinical oncology, bioinformatics, epidemiology, precision medicine, and quality improvement. Key topics included expanding lung cancer screening, neuroendocrine tumor vaccine research, and improving screening adherence.
Overall, the conference sent a clear signal that future cancer prevention and care will increasingly depend on cross-regional collaboration, standardized pathways, and technology, while balancing the needs of younger patients with global resource allocation.
Source:
Compiled from online sources